Skip to main content
Erschienen in: European Radiology 11/2004

01.11.2004 | Nuclear Medicine

Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer

verfasst von: L. S. Freudenberg, G. Antoch, W. Jentzen, R. Pink, J. Knust, R. Görges, S. P. Müller, A. Bockisch, J. F. Debatin, W. Brandau

Erschienen in: European Radiology | Ausgabe 11/2004

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to evaluate the clinical significance of 124I positron emission tomography (PET) using a combined PET/CT tomograph in patients with differentiated thyroid carcinoma and to compare the PET/CT results with 131I whole-body scintigraphy (WBS), dedicated PET and CT alone. Twelve thyroid cancer patients were referred for diagnostic workup and entered complete clinical evaluation, including histology, cytology, thyroglobulin level, ultrasonography, fluorine-18 fluorodeoxyglucose (FDG)-PET, FDG-PET/CT and CT. Lesion-based evaluation showed a lesion delectability of 56, 87 and 100% for CT, 124I-PET, and combined 124I-PET/CT imaging, respectively. Lesion delectability of 131I-WBS was 83%. We conclude that 124I-PET/CT imaging is a promising technique to improve treatment planning in thyroid cancer. It is particularly valuable in patients suffering from advanced differentiated thyroid cancer prior to radio-iodine therapy and in patients with suspected recurrence and potential metastatic disease.
Literatur
1.
Zurück zum Zitat Frilling A, Görges R, Tecklenborg K et al (2000) Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 28:1067–1074CrossRef Frilling A, Görges R, Tecklenborg K et al (2000) Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 28:1067–1074CrossRef
2.
Zurück zum Zitat Alnafisi NS, Driedger AA, Coates G, Moote DJ, Raphael SJ (2000) FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 41:1010–1015PubMed Alnafisi NS, Driedger AA, Coates G, Moote DJ, Raphael SJ (2000) FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 41:1010–1015PubMed
3.
Zurück zum Zitat Chung JK, So Y, Lee JS et al (1999) Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med 40:986–992PubMed Chung JK, So Y, Lee JS et al (1999) Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med 40:986–992PubMed
4.
Zurück zum Zitat Grünwald F, Kalicke T, Feine U et al (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 26:1547–1552CrossRefPubMed Grünwald F, Kalicke T, Feine U et al (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 26:1547–1552CrossRefPubMed
5.
Zurück zum Zitat Hooft L, Hoekstra OS, Deville W et al (2001) Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab 86:3779–3786CrossRefPubMed Hooft L, Hoekstra OS, Deville W et al (2001) Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab 86:3779–3786CrossRefPubMed
6.
Zurück zum Zitat Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G (1998) Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med 39:1542–1546PubMed Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G (1998) Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med 39:1542–1546PubMed
7.
Zurück zum Zitat Frey P, Townsend D, Flattet A et al (1986) Tomographic imaging of the human thyroid using 124I. J Clin Endocrinol Metab 63:918–927PubMed Frey P, Townsend D, Flattet A et al (1986) Tomographic imaging of the human thyroid using 124I. J Clin Endocrinol Metab 63:918–927PubMed
8.
Zurück zum Zitat Lambrecht RM, Woodhouse N, Phillips R et al (1988) Investigational study of iodine-124 with a positron camera. Am J Physiol Imaging 3:197–200PubMed Lambrecht RM, Woodhouse N, Phillips R et al (1988) Investigational study of iodine-124 with a positron camera. Am J Physiol Imaging 3:197–200PubMed
9.
Zurück zum Zitat Crawford DC, Flower MA, Pratt BE et al (1997) Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography. Eur J Nucl Med 24:1470–1478CrossRefPubMed Crawford DC, Flower MA, Pratt BE et al (1997) Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography. Eur J Nucl Med 24:1470–1478CrossRefPubMed
10.
Zurück zum Zitat Erdi YE, Macapinlac H, Larson SM et al (1999) Radiation dose assessment for I-131 therapy of thyroid cancer using I-124 PET imaging. Clin Positron Imaging 2:41–46CrossRefPubMed Erdi YE, Macapinlac H, Larson SM et al (1999) Radiation dose assessment for I-131 therapy of thyroid cancer using I-124 PET imaging. Clin Positron Imaging 2:41–46CrossRefPubMed
11.
Zurück zum Zitat Frey P, Townsend D, Jeavons A, Donath A (1985) In vivo imaging of the human thyroid with a positron camera using 124I. Eur J Nucl Med 10:472–476PubMed Frey P, Townsend D, Jeavons A, Donath A (1985) In vivo imaging of the human thyroid with a positron camera using 124I. Eur J Nucl Med 10:472–476PubMed
12.
Zurück zum Zitat Pentlow KS, Graham MC, Lambrecht RM et al (1996) Quantitative imaging of iodine-124 with PET. J Nucl Med 37:1557–1562PubMed Pentlow KS, Graham MC, Lambrecht RM et al (1996) Quantitative imaging of iodine-124 with PET. J Nucl Med 37:1557–1562PubMed
13.
Zurück zum Zitat Eschmann SM, Reischl G, Bilger K et al (2000) Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET. Eur J Nucl Med 29:760–767CrossRef Eschmann SM, Reischl G, Bilger K et al (2000) Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET. Eur J Nucl Med 29:760–767CrossRef
14.
Zurück zum Zitat Beyer T, Townsend DW, Brun, T et al (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369–1379PubMed Beyer T, Townsend DW, Brun, T et al (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369–1379PubMed
15.
Zurück zum Zitat Townsend DW, Cherry SR (2001) Combined anatomy and function: the path of true image fusion. Eur Radiol 11:1968–1974CrossRefPubMed Townsend DW, Cherry SR (2001) Combined anatomy and function: the path of true image fusion. Eur Radiol 11:1968–1974CrossRefPubMed
16.
Zurück zum Zitat Freudenberg LS, Antoch G, Görges R et al (2002) Combined PET/CT with Iodine-124 in diagnosis of mediastinal micrometastases in thyroid carcinoma. Internet J Radiol 2:2 Freudenberg LS, Antoch G, Görges R et al (2002) Combined PET/CT with Iodine-124 in diagnosis of mediastinal micrometastases in thyroid carcinoma. Internet J Radiol 2:2
17.
Zurück zum Zitat Freudenberg LS, Antoch G, Gorges R et al (2003) Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report. Eur Radiol 13 [Suppl 4]:19–23 Freudenberg LS, Antoch G, Gorges R et al (2003) Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report. Eur Radiol 13 [Suppl 4]:19–23
18.
Zurück zum Zitat Freudenberg LS, Antoch G, Görges R et al (2002) 124I-PET/CT in metastatic follicular thyroid carcinoma. Eur J Nucl Med 29:1106CrossRef Freudenberg LS, Antoch G, Görges R et al (2002) 124I-PET/CT in metastatic follicular thyroid carcinoma. Eur J Nucl Med 29:1106CrossRef
19.
Zurück zum Zitat Fleming ID, Cooper JS, Henson DE (eds) (1997) AJCC cancer staging manual. 5th edn. American Joint Committee on Cancer. Lippincott-Raven, Philadelphia Fleming ID, Cooper JS, Henson DE (eds) (1997) AJCC cancer staging manual. 5th edn. American Joint Committee on Cancer. Lippincott-Raven, Philadelphia
20.
Zurück zum Zitat Knust EJ, Dutschka K, Weinreich R (2000) Preparation of 124I solutions after thermodistillation of irradiated 124TeO2 targets. Appl Radiat Isot 52:181–184CrossRefPubMed Knust EJ, Dutschka K, Weinreich R (2000) Preparation of 124I solutions after thermodistillation of irradiated 124TeO2 targets. Appl Radiat Isot 52:181–184CrossRefPubMed
21.
Zurück zum Zitat Kinahan PE, Townsend DW, Beyer T et al (1998) Attenuation correction for a combined 3D PET/CT scanner. Med Phys 25:2046–2053CrossRefPubMed Kinahan PE, Townsend DW, Beyer T et al (1998) Attenuation correction for a combined 3D PET/CT scanner. Med Phys 25:2046–2053CrossRefPubMed
22.
Zurück zum Zitat Görges R, Fotescu D, Renzing-Köhler K et al (2003) Diagnostic value of high-resolution B-mode and power-mode sonography in the follow up of thyroid cancer. Eur J Ultrasound 16:191–206CrossRefPubMed Görges R, Fotescu D, Renzing-Köhler K et al (2003) Diagnostic value of high-resolution B-mode and power-mode sonography in the follow up of thyroid cancer. Eur J Ultrasound 16:191–206CrossRefPubMed
23.
Zurück zum Zitat International Commission on Radiological Protection (eds) (1998) ICRP publication 80; Addendum to publication 53—radiation dose to patients from radiopharmaceuticals. Ann ICRP 28:3PubMed International Commission on Radiological Protection (eds) (1998) ICRP publication 80; Addendum to publication 53—radiation dose to patients from radiopharmaceuticals. Ann ICRP 28:3PubMed
24.
Zurück zum Zitat Shapiro B, Gross MD (2001) Follow-up of patients with well-differentiated thyroid cancer. In: Biersack HJ, Grünwald F (eds) Thyroid cancer. Spinger, Berlin Heidelberg New York Shapiro B, Gross MD (2001) Follow-up of patients with well-differentiated thyroid cancer. In: Biersack HJ, Grünwald F (eds) Thyroid cancer. Spinger, Berlin Heidelberg New York
Metadaten
Titel
Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer
verfasst von
L. S. Freudenberg
G. Antoch
W. Jentzen
R. Pink
J. Knust
R. Görges
S. P. Müller
A. Bockisch
J. F. Debatin
W. Brandau
Publikationsdatum
01.11.2004
Erschienen in
European Radiology / Ausgabe 11/2004
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-004-2350-0

Weitere Artikel der Ausgabe 11/2004

European Radiology 11/2004 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.